読み込み中
HKSEHealthcareDrug Manufacturers - Specialty & Generic
最新データ
HK$0.178
+HK$0.005 · +2.89%
Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
最新データ
HK$0.178
+HK$0.005 · +2.89%
日中の時刻はHKTです。市場データは遅延する場合があります。
Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
日中の時刻はHKTです。市場データは遅延する場合があります。
Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（CNY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2828.2万 CNY | 2535.9万 CNY | 2462.9万 CNY | 2533万 CNY | 2612.7万 CNY |
| 売上原価 | 1051.3万 CNY | 828.7万 CNY | 853.6万 CNY | 841.6万 CNY | 967.1万 CNY |
| 粗利益 | 1776.9万 CNY | 1707.2万 CNY | 1609.3万 CNY | 1691.4万 CNY | 1645.6万 CNY |
| 研究開発 | 392.5万 CNY | 282.5万 CNY | 255.3万 CNY | 248.3万 CNY | 243.7万 CNY |
| 販売・一般管理 | 2147万 CNY | 1925.8万 CNY | 1849.1万 CNY | 1875.4万 CNY | 1769.9万 CNY |
| 営業費用 | 2633.6万 CNY | 2208.3万 CNY | 2348.4万 CNY | 2200.4万 CNY | 2103.4万 CNY |
| 受取利息 | 31.56万 CNY | 51.2万 CNY | 40.4万 CNY | 40.9万 CNY | 17.9万 CNY |
| 支払利息 | 23.96万 CNY | 8.6万 CNY | 5.3万 CNY | 5.5万 CNY | 10.2万 CNY |
| 減価償却費と償却費 | 371.6万 CNY | 333.4万 CNY | 317.9万 CNY | 314万 CNY | 294.9万 CNY |
| 営業利益 | −781万 CNY | −568.8万 CNY | −739.1万 CNY | −509万 CNY | −432.95万 CNY |
| 純利益 | −500.6万 CNY | −415.8万 CNY | −578.2万 CNY | −307.5万 CNY | −422万 CNY |
会社概要が更新されました 2026年10月17日.
直近の発表実績
直近の発表実績
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
